CORZ
The table below shows Core Scientific, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $115.24M | $81.10M | $78.63M | $79.53M | - | $95.35M |
| Cost of revenue | $85.14M | $77.20M | $73.60M | $71.31M | - | $95.51M |
| Gross profit | $30.11M | $3.90M | $5.03M | $8.21M | - | -$156.00K |
| R&D | - | - | - | - | - | $2.84M |
Core Scientific, Inc. reported annual revenue of $319.02M for fiscal year 2025. That is down 37.5% from $510.67M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $60.32M (FY 2020) to $319.02M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $44.85M |
| $69.35M |
| $56.94M |
| $32.29M |
| - |
| $40.35M |
| Operating income | -$310.42M | -$54.79M | -$26.28M | -$47.04M | -$65.39M | -$41.22M |
| Income tax | $600.00K | $125.00K | $158.00K | $205.00K | - | $134.00K |
| Net income | -$347.19M | -$144.03M | -$936.80M | $576.25M | -$291.15M | -$455.26M |
| EPS (diluted) | -$1.06 | -$0.45 | -$0.04 | $1.24 | -$0.69 | -$1.17 |